Cannabis Company Tilray May Pivot to Fruit & Veg Cultivation

January 10, 2023 · Highly Capitalized

NEW YORK- After Canadian cannabis company Tilray Brands Inc. TLRY, +1.09% said it had lost money in the second quarter, its stock fell 3.7% in premarket trading on Monday.

In contrast to a profit of $5.8 million, or breakeven per share, for same time last year, Tilray recorded a loss of $61.64 million, or 11 cents per share, for the second quarter.

The adjusted loss was 6 cents per share, in line with the analysts’ forecasts. The second quarter’s net revenue for the business dropped from $155.15 million to $144.14 million. On a constant currency basis, net revenue in the most recent quarter totaled $157.6 million.

Analysts predicted $154.8 million in revenue.

Simon mentioned the absence of congressional action on American legalization as the reason for this poor performance.

Tilray’s U.S. distribution network remains mainly inactive because Congress allowed cannabis to remain federally illegal.

During the call, Simon stated that there were food shortages worldwide for lettuce, tomatoes, and strawberries. How can we start growing fruits and vegetables at some of these facilities if we have excess capacity so that we can feed everyone on the planet?

Simon emphasized that such a change would only be temporary and that Tilray’s main focus would remain on the global cannabis market. The business is already well-established in Canada and Europe.

After the earnings call, Simon also told Bloomberg that once the U.S. and more European nations fully legalize cannabis, any production facilities that are converted to use for produce growth might be converted back to use for cannabis growing.

Tilray now owns three alcoholic beverage producers, including SweetWater Brewing Co. and Breckenridge Distillery, in addition to Montauk beer, and it is considering other acquisitions in the hemp sector to increase the reach of its hemp-based food items.

In addition, Simon stated that Tilray is seeking to grow share in those markets as it waits for lawmakers to take action on legalizing cannabis at the national level. (Full Story)

In category:Business
Next Post

Cannabis Lounges Could Be the Next Big Hotel Perk

Chris Chiari stood in front of 420 E 11th Avenue in Denver 12 years ago having just sold his home in Florida. The building there looked like a castle, he says. It was on the market. "I pointed up to…
Previous Post

Is the US Cannabis Industry Just a Front for the Russian Mob?

Roman Abramovich, a Russian billionaire and former owner of the English Premier League's Chelsea Football Club, has been discreetly investing in cannabis enterprises for years. According to Forensic News, the news outlet that obtained the secret documents, Roman Abramovich has contributed…
Random Post

New Bipartisan Washington Bill Would Legalize Psilocybin Therapy For Veterans And First Responders

Bipartisan Washington State lawmakers prefiled a Senate bill last week that would allow nonprofits to provide psilocybin services to clients 21 and older so long as the organizations “have an explicit goal of promoting wellness for and assisting military veterans…
Random Post

Expand Your Mind at the Best Weed Museums in the U.S.

THE FIRST THING YOU SEE upon entering the Core Social Justice Cannabis Museum in Boston’s Jamaica Plain neighborhood is a digital stained glass window stamped “Cannfessional.” Behind it is a small sound booth, wrapped in cloud-print wallpaper, with a glowing neon chair and…
Random Post

New Report Projects Global Recreational Cannabis Market To Nearly Double by 2027

A new report projects that the global recreational marijuana market will nearly double over the next four years, with legal sales of adult-use cannabis climbing to almost $50 billion per year by 2027. The report, from U.K.-based cannabis data, media…
Random Post

Would You Take Weed and Magic Mushrooms Together in One Pill? - Doctors Working at CaaMTech on New Medical Breakthrough

Researchers Aim To Combine Psilocybin and Cannabis Into Single Medical Treatment According to a product patent from the renowned marijuana laboratory, CaaMTech, substantial strides have been made in developing a comprehensive treatment that combines cannabinoids and psilocybin for treating both physical and…